366 related articles for article (PubMed ID: 33814268)
1. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa.
Kishnani PS; Del Angel G; Zhou S; Rush ET
Mol Genet Metab; 2021 May; 133(1):113-121. PubMed ID: 33814268
[TBL] [Abstract][Full Text] [Related]
2. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
Kishnani PS; Rockman-Greenberg C; Rauch F; Bhatti MT; Moseley S; Denker AE; Watsky E; Whyte MP
Bone; 2019 Apr; 121():149-162. PubMed ID: 30576866
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia.
Seefried L; Kishnani PS; Moseley S; Denker AE; Watsky E; Whyte MP; Dahir KM
Bone; 2021 Jan; 142():115664. PubMed ID: 32987199
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial.
Kitaoka T; Tajima T; Nagasaki K; Kikuchi T; Yamamoto K; Michigami T; Okada S; Fujiwara I; Kokaji M; Mochizuki H; Ogata T; Tatebayashi K; Watanabe A; Yatsuga S; Kubota T; Ozono K
Clin Endocrinol (Oxf); 2017 Jul; 87(1):10-19. PubMed ID: 28374482
[TBL] [Abstract][Full Text] [Related]
5. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B
Whyte MP; Zhang F; Mack KE; Wenkert D; Gottesman GS; Ericson KL; Cole JT; Coburn SP
Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
[TBL] [Abstract][Full Text] [Related]
6. Hypophosphatasia: presentation and response to asfotase alfa.
Alsarraf F; Ali DS; Almonaei K; Al-Alwani H; Khan AA; Brandi ML
Osteoporos Int; 2024 Apr; 35(4):717-725. PubMed ID: 37993691
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphatasia: An overview For 2017.
Whyte MP
Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
[TBL] [Abstract][Full Text] [Related]
8. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia.
Stürznickel J; Schmidt FN; von Vopelius E; Delsmann MM; Schmidt C; Jandl NM; Oheim R; Barvencik F
Bone; 2021 Feb; 143():115794. PubMed ID: 33301963
[TBL] [Abstract][Full Text] [Related]
9. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
Whyte MP
J Bone Miner Res; 2017 Apr; 32(4):667-675. PubMed ID: 28084648
[TBL] [Abstract][Full Text] [Related]
10. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
Scott LJ
Drugs; 2016 Feb; 76(2):255-62. PubMed ID: 26744272
[TBL] [Abstract][Full Text] [Related]
11. Genotype-Phenotype Associations in 72 Adults with Suspected ALPL-Associated Hypophosphatasia.
Jandl NM; Schmidt T; Rolvien T; Stürznickel J; Chrysostomou K; von Vopelius E; Volk AE; Schinke T; Kubisch C; Amling M; Barvencik F
Calcif Tissue Int; 2021 Mar; 108(3):288-301. PubMed ID: 33191482
[TBL] [Abstract][Full Text] [Related]
12. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.
Whyte MP; Rockman-Greenberg C; Ozono K; Riese R; Moseley S; Melian A; Thompson DD; Bishop N; Hofmann C
J Clin Endocrinol Metab; 2016 Jan; 101(1):334-42. PubMed ID: 26529632
[TBL] [Abstract][Full Text] [Related]
13. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
Kishnani PS; Rush ET; Arundel P; Bishop N; Dahir K; Fraser W; Harmatz P; Linglart A; Munns CF; Nunes ME; Saal HM; Seefried L; Ozono K
Mol Genet Metab; 2017 Sep; 122(1-2):4-17. PubMed ID: 28888853
[TBL] [Abstract][Full Text] [Related]
14. Hypophosphatasia: A Unique Disorder of Bone Mineralization.
Villa-Suárez JM; García-Fontana C; Andújar-Vera F; González-Salvatierra S; de Haro-Muñoz T; Contreras-Bolívar V; García-Fontana B; Muñoz-Torres M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919113
[TBL] [Abstract][Full Text] [Related]
15. Urine phosphoethanolamine is a specific biomarker for hypophosphatasia in adults.
Shajani-Yi Z; Ayala-Lopez N; Black M; Dahir KM
Bone; 2022 Oct; 163():116504. PubMed ID: 35878747
[TBL] [Abstract][Full Text] [Related]
16. Asfotase alfa therapy for children with hypophosphatasia.
Whyte MP; Madson KL; Phillips D; Reeves AL; McAlister WH; Yakimoski A; Mack KE; Hamilton K; Kagan K; Fujita KP; Thompson DD; Moseley S; Odrljin T; Rockman-Greenberg C
JCI Insight; 2016 Jun; 1(9):e85971. PubMed ID: 27699270
[No Abstract] [Full Text] [Related]
17. Hypophosphatasia: From Diagnosis to Treatment.
Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry.
Kishnani PS; Martos-Moreno GÁ; Linglart A; Petryk A; Messali A; Fang S; Rockman-Greenberg C; Ozono K; Högler W; Seefried L; Dahir KM
Orphanet J Rare Dis; 2024 Mar; 19(1):109. PubMed ID: 38459585
[TBL] [Abstract][Full Text] [Related]
19. Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.
Scott LJ
BioDrugs; 2016 Feb; 30(1):41-8. PubMed ID: 26832358
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
